Boston Scientific Announces Availability of New Connector System Designed to Simplify the Implant Procedure for Cardiac Devices

PARIS, March 24, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
European commercial availability of the Company's new cardiac rhythm
management connector system, which consists of the ENDOTAK RELIANCE(R) 4-SITE
defibrillation lead and compatible COGNIS(R) cardiac resynchronization
therapy defibrillators (CRT-Ds) and TELIGEN(R) implantable cardioverter
defibrillators (ICDs). The system is designed to simplify the implant
procedure by combining three terminals [...]

Property Industry has Critical Role in Improving Well-being in Britain

LONDON, March 24, 2010 – A new report launched today, Building Quality of Life,
commissioned by Development Securities PLC, one of the UK's leading property
companies, reveals the huge pressures on our general happiness and well-being
and the key contribution that the property industry can make to improving
quality of life in Britain.

The research, [...]

ViroPharma Announces Acceptance of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Marketing Authorization Application (MAA) by European Medicines Agency (EMA)

EXTON, Pennsylvania, March 24, 2010 – ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European
Medicines Agency (EMA) has accepted the filing of its Marketing Authorization
Application (MAA) for Cinryze for acute treatment and prophylaxis against
hereditary angioedema (HAE), which was submitted through the centralized
procedure in March 2010. ViroPharma is seeking European approval for both
prevention and treatment [...]

The CPM Resource Center Healthcare Consortium Earns Prestigious Award From The National Academies of Practice Interdisciplinary Group Recognition Award Lauds CPM Resource Center’s Healthcare Consortium

GRAND RAPIDS, Michigan, March 24, 2010 – The Healthcare Consortium of the Clinical Practice Model
Resource Center (CPMRC, www.cpmrc.com/), an Elsevier company, is the
2010 recipient of the National Academies Practice (NAP) Interdisciplinary
Group Recognition Award. Bestowed annually on groups that make "enduring
contributions to interdisciplinary education and practice," the NAP
(www.napractice.org/ ) award recognizes CPMRC's 25-year-old Healthcare
Consortium of [...]

Agendia Launches BluePrint(TM) Expanding Breast Cancer Product Offering

New Service to Provide Breast Cancer Molecular Subtyping
HUNTINGTON BEACH, California and AMSTERDAM, March 24, 2010 – Agendia, a world leader in molecular cancer diagnostics, today announced
that its breast cancer product offering, consisting of breast cancer
recurrence test MammaPrint(R), and TargetPrint(TM), has been expanded with
BluePrint (TM) to report important additional information on tumor subtypes.
This new service [...]